knowledge -WSS

knowledge

author：fashion 2025-08-12 09:09:42 - browse：232

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FDA approves updated Covid vaccines

WSS

Food makers to regulators: Ultra

Popular nasal decongestant doesn't actually relieve congestion

A Theranos scientist

FDA panel endorses Alnylam’s heart drug — after picking it apart

White House touts steps to stem shortages of cancer treatments

Food makers to regulators: Ultra

entertainment

knowledge

focus

Medicare details structure of new drug price negotiation program

Regeneron agrees to White House price limits on anti

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Long Covid needs a new name — and a new frame

The high cost of giving birth even with insurance

FDA seeking to stop procedures at two unregulated stem cell clinics

Affirmative action in medical school literally saved lives

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Hollywood unions extend contract negotiations for actors

Long Covid needs a new name — and a new frame

knowledge

More hospitals are billing patients as online messages surge

FDA approves updated Covid vaccines

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

New Covid vaccine is recommended for everyone 6 months or older

Private equity could exacerbate cardiology's overuse problem, experts fear

explore

focus

explore

leisure time